JL
KD
MCBCDZ
SSPHSLPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Prothenaprothena.com  JJKDJL |
Prothena is a biopharmaceutical company developing a pipeline of novel therapeutics targeting protein dysregulation in neurodegene | — | — | — |
Arkuda Therapeuticsarkudatx.com ME  LS |
Arkuda Therapeutics is a biotechnology company developing medicines to treat neurodegenerative disease, leveraging new insights in | Watertown, Massachusetts | 1-10 | — |
Amyl Therapeuticsamyltx.com  DT PVJG |
amyltx.com is a domain that currently serves only a web server's default page — no website content exists at this address, so the | Liège, Walloon Region | 5000+ | — |
Attralusattralus.com  EC SSSB |
Attralus is a clinical-stage biopharmaceutical company developing pan-amyloid removal (PAR) therapeutics that bind to and remove t | Naples, Florida | 11-50 | — |
Alkahestalkahest.com  MK SL EO |
Alkahest, a Grifols subsidiary, is a research and drug discovery company developing plasma-derived therapies for neurological dise | San Carlos, California | 11-50 | — |
Acurexacurex.com  WD SP GL |
Acurex is a biotechnology company developing oral small-molecule therapeutics that fundamentally modify the course of neurodegener | San Carlos, California | 11-50 | — |
Acumen Pharmaceuticalsacumenpharm.com LSJB  LR |
Acumen Pharmaceuticals is a biotechnology company developing targeted therapies for Alzheimer's disease, with its most advanced ca | Boston, Massachusetts | 51-200 | — |
Aliada Therapeuticsaliadatx.com |
Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases, founded in 202 | Boston, Massachusetts | 11-50 | — |
Alzheonalzheon.com  JSKMSK |
Alzheon is a clinical-stage biopharmaceutical company developing valiltramiprosate (ALZ-801), an investigational oral anti-amyloid | Framingham, Massachusetts | 11-50 | — |
| Run live for more | ||||
Prothena is a biopharmaceutical company developing a pipeline of novel therapeutics targeting protein dysregulation in neurodegenerative and rare peripheral amyloid diseases, including Parkinson's disease, ATTR amyloidosis, and Alzheimer's disease.
Companies like Prothena include Arkuda Therapeutics, Amyl Therapeutics, Attralus, Alkahest, Acurex. See the full list of 24 competitors and alternatives above.
Key decision-makers and buying contacts at Prothena are listed above, including leaders across executive, finance, sales and operations.